ArticleEMBO molecular medicine2019

Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer.

Mi Ran Yun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.